BSG and neoplasm: Treatment with CD147 recombinant protein (BP4745, BOSTER) in RT4 cells, which is a relatively low-grade malignant cell line, significantly contributed to GSDMD expression, leading to increased tumor proliferation as characterized by Ki-67 expression (Figure 2(b)).